Mangoceuticals (MGRX) Treasury Shares (2022 - 2024)

Mangoceuticals (MGRX) has 3 years of Treasury Shares data on file, last reported at $1.4 million in Q1 2024.

• For the quarter ending Q1 2024, Treasury Shares rose 10.8% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2024 stood at $1.4 million (up 10.8% YoY), and the FY2023 full-year result was $1.3 million, up 171.95% from the prior year.
• Treasury Shares climbed to $1.4 million in Q1 2024, from $1.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.4 million in Q1 2024 to a low of -$1.9 million in Q4 2022.
• A 3-year average of $363699.8 and a median of $1.2 million in 2023 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares jumped 171.95% in 2023 and increased 10.8% in 2024, its largest moves.
• Tracing MGRX's Treasury Shares over 3 years: stood at -$1.9 million in 2022, then jumped by 171.95% to $1.3 million in 2023, then grew by 3.13% to $1.4 million in 2024.
• Business Quant data shows MGRX's Treasury Shares at $1.4 million in Q1 2024, $1.3 million in Q4 2023, and -$992134.0 in Q3 2023.